Glaukos (GKOS) Stock Price

$103.3 0%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    7

  • Fundamental

    8

  • Technical

    4

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Glaukos, AI stock picks, stock alerts and much more.

Sign up

GKOS AI Stock Analysis

AI stock analysis for GKOS is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Glaukos (GKOS) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Glaukos (GKOS) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Glaukos (GKOS), currently trading at $103.3, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About GKOS

LSE

  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.

  • Symbol

    GKOS

  • Market

    NYSE

  • Industry

    Medical - Devices

  • Market Cap

    5.9B

Similar Stocks

ABT Abbott Laboratories
ABT		 $136
1.2%
6
BSX Boston Scientific
BSX		 $107.4
0.8%
7
EW Edwards Lifesciences
EW		 $78.21
0.00%
5
MDT Medtronic
MDT		 $87.17
1.3%
7
SYK Stryker
SYK		 $395.6
0.5%
6

News

Glaukos Announces EU MDR Certification for iStent infinite® and Other Leading MIGS Therapies

Glaukos Announces EU MDR Certification for iStent infinite® and Other Leading MIGS Therapies
June 25, 2025. businesswire.com
Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell

Glaukos to Celebrate 10th Anniversary of IPO Listing with NYSE Closing Bell
June 25, 2025. businesswire.com
What Makes Glaukos (GKOS) a New Buy Stock

What Makes Glaukos (GKOS) a New Buy Stock
June 16, 2025. zacks.com
Glaukos (GKOS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Glaukos (GKOS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
May 1, 2025. zacks.com

GKOS Alternative Data

Web Traffic

Glaukos receives an estimated 19406 monthly visitors to glaukos.com.

  • Web Traffic

    19406

  • Change from Previous Month

    3.4%

  • 3 Month Change

    22.4%

  • YoY Change

    22.4%

Twitter Followers

Glaukos has 1,626 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.3% over the last month.

  • Twitter Followers

    1626

  • Daily Change

    0%

  • 1 Month Change

    0.3%

  • 3 Month Change

    0.4%

  • YoY Change

    0.4%

Facebook Engagement

Glaukos has engaged 357 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    357

  • Daily Change

    0%

  • 1 Month Change

    147.9%

  • 3 Month Change

    233.6%

  • YoY Change

    233.6%

Instagram Followers

Glaukos has 3,455 Instagram Followers on its main Instagram account, up by 1.6% over the last month.

  • Instagram Followers

    3455

  • Daily Change

    0.1%

  • 1 Month Change

    1.6%

  • 3 Month Change

    6.4%

  • YoY Change

    6.4%

LinkedIn Followers

30,561 are following Glaukos on LinkedIn, up by 2.4% over the last month.

  • LinkedIn Followers

    30561

  • Daily Change

    0.1%

  • 1 Month Change

    2.4%

  • 3 Month Change

    6.9%

Job Postings

Glaukos has an estimated 24 open job postings, which is down -14.3% over the last month.

  • Job Postings

    24

  • Daily Change

    4%

  • 1 Month Change

    14.3%

  • 3 Month Change

    17.2%

  • YoY Change

    17.2%

LinkedIn Employees

According to LinkedIn, Glaukos has 948 employees, up by 2.6% over the last month.

  • LinkedIn Employees

    948

  • Daily Change

    0%

  • 1 Month Change

    2.6%

  • 3 Month Change

    5.2%

  • YoY Change

    5.2%

Reddit Mentions

Glaukos has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Business Outlook

According to employee reviews, the business outlook among employees at Glaukos is 89 out of 100 (very bullish).

  • Business Outlook

    89

  • Change from Previous Month

    0%

  • 3 Month Change

    1.1%

  • YoY Change

    1.1%

News Mentions

Glaukos was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    100%

GKOS Financials

GKOS Key Metrics

  • Total Revenue

    $106.7M

  • Net Income

    -$18.1M

  • Earnings per Share

    -$0.32

  • Free cash flow

    -$20.5M

  • EBITDA

    -$20.7M

  • EBITDA Ratio

    -0.193861

  • Total Assets

    $966.2M

GKOS 2-year Revenue & Income
GKOS 2-year Free Cash Flow

GKOS Technicals

GKOS SMA
GKOS RSI

FAQ

What's the current price of Glaukos (GKOS) Stock?
The price of an Glaukos (GKOS) share is $103.3.

What's the market cap of Glaukos?
The current market cap of Glaukos is 5.9B.

Should I buy or sell GKOS?
Multiple alternative data signals suggest that Glaukos stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.

Is Glaukos a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Glaukos stock. The bullish indicators suggest that Glaukos' growth prospects and market position may lead to a positive performance in the foreseeable future.

Is now a good time to buy Glaukos (GKOS) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Glaukos stock, given the bullish outlook.

What are some stocks similar to Glaukos (GKOS) that investors often compare it to?
Glaukos (GKOS) is often compared to similar stocks such as Abbott Laboratories, Boston Scientific, Edwards Lifesciences, Medtronic and Stryker.

What is the forecast for Glaukos' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Glaukos' stock price to be around $111.2 in 2026. Starting from the current price of $103.3, this represents a 7.6% change in price, indicating a bullish outlook for the stock.

How to buy Glaukos (GKOS) Stock?
Glaukos stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Glaukos shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.